ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I and pharmacoklnetic (PK) study of irinotecan (CPT-11) and cisplatin in patients with solid tumors: Preliminary results
European Journal of Cancer
◽
10.1016/s0959-8049(97)86044-3
◽
1997
◽
Vol 33
◽
pp. S251
◽
Cited By ~ 1
Author(s):
M.J.A. de Jonge
◽
A. Spareboom
◽
A.S.Th. Planting
◽
M.E.L van der Burg
◽
P. de Bruijn
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Preliminary Results
Download Full-text
Related Documents
Cited By
References
A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: Preliminary results
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.3599
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 3599-3599
◽
Cited By ~ 24
Author(s):
N. Isambert
◽
G. Freyer
◽
S. Zanetta
◽
C. Falandry
◽
K. Soussan Lazard
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Preliminary Results
◽
Vegf Trap
Download Full-text
282 POSTER Preliminary results of a Phase I accelerated dose-escalation, pharmacokinetic and pharmacodynamic study of PF-03814735, an oral Aurora kinase A and B inhibitor, in patients with advanced solid tumors
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(08)72216-x
◽
2008
◽
Vol 6
(12)
◽
pp. 91
◽
Cited By ~ 1
Author(s):
P. Schöffski
◽
H. Dumez
◽
S.F. Jones
◽
C. Fowst
◽
P. Gerletti
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Aurora Kinase
◽
Advanced Solid Tumors
◽
Aurora Kinase A
◽
Preliminary Results
◽
Pharmacodynamic Study
◽
Kinase A
Download Full-text
164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors
Annals of Oncology
◽
10.1016/j.annonc.2021.10.183
◽
2021
◽
Vol 32
◽
pp. S1453-S1454
Author(s):
M.R. Sharma
◽
R.D. Carvajal
◽
G.J. Hanna
◽
Y.K. Kang
◽
J. Lee
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Preliminary Results
◽
Antibody Conjugate
Download Full-text
A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus weekly gemcitabine (Gem) in patients (pts) with advanced solid tumors: preliminary results
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.3558
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 3558-3558
◽
Cited By ~ 7
Author(s):
A. Patnaik
◽
M. Pipas
◽
L. S. Rosen
◽
L. Wood
◽
K. Phipps
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Preliminary Results
◽
Vegf Trap
Download Full-text
620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion
Annals of Oncology
◽
10.1016/j.annonc.2021.08.1133
◽
2021
◽
Vol 32
◽
pp. S657-S659
Author(s):
E. Shenderov
◽
G.H.G. Mallesara
◽
P.J. Wysocki
◽
W. Xu
◽
R. Ramlau
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Advanced Solid Tumors
◽
Antibody Drug Conjugate
◽
Preliminary Results
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort
10.1158/1535-7163.targ-19-c027
◽
2019
◽
Author(s):
Johanna Bendell
◽
Susanna V Ulahannan
◽
Quincy Chu
◽
Manish Patel
◽
Ben George
◽
...
Keyword(s):
Colorectal Cancer
◽
Phase I
◽
Metastatic Colorectal Cancer
◽
Solid Tumors
◽
Dose Finding
◽
Advanced Solid Tumors
◽
Preliminary Results
◽
Finding Study
◽
Dose Finding Study
Download Full-text
Phase I trial of a nucleoside analog CP-4055 given daily for 5 days every 3 weeks in patients (pts) with advanced solid tumors - preliminary results
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.2049
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 2049-2049
◽
Cited By ~ 2
Author(s):
S. Aamdal
◽
S. Dueland
◽
M. J. Lind
◽
H. Thomas
◽
C. R. Franks
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Trial
◽
Nucleoside Analog
◽
Advanced Solid Tumors
◽
Preliminary Results
Download Full-text
Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors
Annals of Oncology
◽
10.1093/annonc/mdz157.009
◽
2019
◽
Vol 30
◽
pp. iv125
Author(s):
E. Garralda
◽
W. Fiedler
◽
I. Matos
◽
C. Rolling
◽
M. Kebenko
◽
...
Keyword(s):
Colorectal Cancer
◽
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Preliminary Results
Download Full-text
Biweekly docetaxel (DOC), gemcitabine (GEM), oxaliplatin (LOHP) in heavily pretreated patients with solid tumors — Preliminary results of a phase I study
European Journal of Cancer
◽
10.1016/s0959-8049(99)81576-7
◽
1999
◽
Vol 35
◽
pp. S288
◽
Cited By ~ 2
Author(s):
T. Büchele
◽
A. Grothey
◽
W. Voigt
◽
T. Kegel
◽
C. Rie
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Preliminary Results
◽
Heavily Pretreated
◽
Pretreated Patients
Download Full-text
Abstract C173: A first-in-human Phase I study of DS-3078a, an oral TORC1/2 inhibitor, in patients with advanced solid tumors: Preliminary results.
10.1158/1535-7163.targ-13-c173
◽
2013
◽
Cited By ~ 2
Author(s):
Marta Capelan
◽
Prasana Kumar
◽
Anthony W. Tolcher
◽
Andrea Zivi
◽
Madhuri Desai
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Advanced Solid Tumors
◽
Preliminary Results
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close